[Does the administration of dipyridamole affect the ventilatory capacity of patients with chronic obstructive lung disease?].
Nøjgaard
Camilla
C
H:S Hvidovre Hospital, Klinisk Fysiologisk/Nuklearmedicinsk Afdeling. mille@dadlnet.dk
Søndergaard
Susanne Bonnichsen
SB
Madsen
Jan Lysgård
JL
Møller
Søren
S
D000368:Aged; D004176:Dipyridamole / Q000008:administration & dosage* / Q000009:adverse effects; D005260:Female; D006801:Humans; D007262:Infusions, Intravenous; D008297:Male; D008875:Middle Aged; D017202:Myocardial Ischemia / Q000150:complications / Q000000981:diagnostic imaging*; D010726:Phosphodiesterase Inhibitors / Q000008:administration & dosage* / Q000009:adverse effects; D029424:Pulmonary Disease, Chronic Obstructive / Q000150:complications / Q000503:physiopathology*; D012123:Pulmonary Ventilation / Q000187:drug effects*; D011877:Radionuclide Imaging; D012307:Risk Factors; D013147:Spirometry
D010726:Phosphodiesterase Inhibitors; D004176:Dipyridamole